Mack Roach

30.4k total citations · 7 hit papers
374 papers, 16.2k citations indexed

About

Mack Roach is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mack Roach has authored 374 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 310 papers in Pulmonary and Respiratory Medicine, 185 papers in Radiation and 86 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mack Roach's work include Prostate Cancer Diagnosis and Treatment (250 papers), Prostate Cancer Treatment and Research (203 papers) and Advanced Radiotherapy Techniques (183 papers). Mack Roach is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (250 papers), Prostate Cancer Treatment and Research (203 papers) and Advanced Radiotherapy Techniques (183 papers). Mack Roach collaborates with scholars based in United States, Canada and France. Mack Roach's co-authors include Howard M. Sandler, William U. Shipley, Gerald E. Hanks, Gerald H. Sokol, Howard D. Thames, Paul F. Schellhammer, Katsuto Shinohara, Richard K. Valicenti, Jean Pouliot and Barby Pickett and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mack Roach

362 papers receiving 15.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

2006 2.1k citations Mack Roach, Gerald E. Hanks et al. International Journal of Radiation Oncology*Biology*Physics profile →
Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases

2005 528 citations Robert Ivker, Mack Roach et al. profile →
Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

2003 471 citations Mack Roach, Michelle DeSilvio et al. profile →
Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

2008 451 citations Mack Roach, Kyounghwa Bae et al. profile →
High-risk prostate cancer—classification and therapy

2014 339 citations Mack Roach et al. profile →
Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline

2013 289 citations Ian M. Thompson, Richard K. Valicenti et al. profile →
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature

2014 256 citations Mack Roach, Alberto Briganti et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mack Roach United States	64	12.7k	7.1k	3.8k	2.3k	1.7k	374	16.2k
Jeff M. Michalski United States	64	11.8k 0.9×	7.4k 1.0×	4.8k 1.2×	2.2k 1.0×	1.9k 1.1×	373	15.7k
Deborah A. Kuban United States	57	11.9k 0.9×	7.3k 1.0×	3.4k 0.9×	2.0k 0.9×	1.5k 0.9×	272	14.9k
Alan Pollack United States	65	12.7k 1.0×	6.3k 0.9×	3.2k 0.8×	2.2k 0.9×	2.1k 1.2×	465	17.4k
Steven A. Leibel United States	71	11.1k 0.9×	8.5k 1.2×	6.0k 1.5×	2.8k 1.2×	1.7k 1.0×	208	17.1k
Patrick A. Kupelian United States	69	10.1k 0.8×	7.9k 1.1×	4.6k 1.2×	1.6k 0.7×	1.1k 0.7×	342	13.8k
Gerald E. Hanks United States	76	13.9k 1.1×	6.6k 0.9×	3.3k 0.9×	3.9k 1.7×	2.2k 1.3×	393	19.4k
David P. Dearnaley United Kingdom	73	11.3k 0.9×	4.6k 0.7×	5.0k 1.3×	4.3k 1.8×	3.7k 2.1×	416	18.4k
Mitchell S. Anscher United States	65	6.6k 0.5×	3.4k 0.5×	5.0k 1.3×	2.5k 1.1×	2.4k 1.4×	268	12.8k
Anthony L. Zietman United States	66	10.6k 0.8×	4.0k 0.6×	1.8k 0.5×	5.6k 2.4×	2.9k 1.7×	330	16.8k
Guy Storme Belgium	48	6.0k 0.5×	4.1k 0.6×	2.9k 0.7×	1.7k 0.7×	2.2k 1.3×	255	10.8k

Countries citing papers authored by Mack Roach

Since Specialization

Citations

This map shows the geographic impact of Mack Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mack Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mack Roach more than expected).

Fields of papers citing papers by Mack Roach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mack Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mack Roach. The network helps show where Mack Roach may publish in the future.

Co-authorship network of co-authors of Mack Roach

This figure shows the co-authorship network connecting the top 25 collaborators of Mack Roach. A scholar is included among the top collaborators of Mack Roach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mack Roach. Mack Roach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roach, Mack, et al.. (2024). MRI-Linac–Based Radiotherapy—Promising or Hype?. JAMA Oncology. 10(10). 1313–1314. 1 indexed citations

Wu, Susan, Anthony Wong, Katsuto Shinohara, et al.. (2021). Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Definitive Radiation. Practical Radiation Oncology. 11(6). 515–526. 10 indexed citations

Han, Harry J., et al.. (2020). Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer. Therapeutic Advances in Medical Oncology. 12. 3863551124–3863551124. 15 indexed citations

Hsu, I‐Chow, Joseph P. Rodgers, Katsuto Shinohara, et al.. (2020). Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate. International Journal of Radiation Oncology*Biology*Physics. 110(3). 700–707. 17 indexed citations

Robinson, Clifford G., J. Contreras, T.A. DeWees, et al.. (2018). Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC). International Journal of Radiation Oncology*Biology*Physics. 102(3). S17–S17. 3 indexed citations

Hamstra, Daniel A., Kyounghwa Bae, Gerald E. Hanks, et al.. (2014). Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer. 121(6). 844–852. 2 indexed citations

Garcia, Maurice M., Alexander Gottschalk, Jonathan Brajtbord, et al.. (2014). Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS ONE. 9(3). e89754–e89754. 17 indexed citations

Stephenson, Andrew J., M. Bolla, Alberto Briganti, et al.. (2011). Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy. European Urology. 61(3). 443–451. 85 indexed citations

Hoppe, Richard T., Theodore L. Phillips, Mack Roach, & Steven A. Leibel. (2010). Leibel and Phillips textbook of radiation oncology. Elsevier eBooks. 34 indexed citations

10.

Roach, Mack, Gerald E. Hanks, Howard D. Thames, et al.. (2006). Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. International Journal of Radiation Oncology*Biology*Physics. 65(4). 965–974. 2071 indexed citations breakdown →

11.

Roach, Mack, Michelle DeSilvio, Richard K. Valicenti, et al.. (2006). Whole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. International Journal of Radiation Oncology*Biology*Physics. 66(3). 647–653. 141 indexed citations

12.

Abdel–Wahab, May, Brian Berkey, Awtar Krishan, et al.. (2006). Influence of Number of CAG Repeats on Local Control in the RTOG 86-10 Protocol. American Journal of Clinical Oncology. 29(1). 14–20. 16 indexed citations

13.

Carey, Thomas E., Jean B. deKernion, Robert Dreicer, et al.. (2005). Bridging the gap: Health disparity research initiatives through the department of defense (DOD) congressionally directed medical research programs (CDMRP) prostate cancer research program (PCRP). Cancer Research. 65. 599–599. 4 indexed citations

14.

Heron, Dwight E., Karen D. Godette, V. Elayne Arterbery, et al.. (2003). Radiation medicine innovations for the new millenium.. PubMed Central. 95(1). 55–63. 14 indexed citations

15.

Shu, Hui‐Kuo G., Thierry Jahan, Mack Roach, et al.. (2002). Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. Journal of Thoracic and Cardiovascular Surgery. 124(6). 1183–1189. 74 indexed citations

16.

Michalski, Jeff M., Kathryn Winter, James A. Purdy, et al.. (2002). Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on radiation therapy oncology group 9406. Seminars in Radiation Oncology. 12(1). 75–80. 23 indexed citations

17.

Ryu, Janice, Kathryn Winter, Jeff M. Michalski, et al.. (2002). Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 gy). International Journal of Radiation Oncology*Biology*Physics. 54(4). 1036–1046. 123 indexed citations

18.

Jani, Ashesh B., Florin Vaida, Gerald E. Hanks, et al.. (2001). Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate‐specific antigen (PSA), stage, and grade trends in the PSA era. International Journal of Cancer. 96(6). 363–371. 46 indexed citations

19.

Campbell, Timothy, John C. Blasko, E. David Crawford, et al.. (2001). Clinical staging of prostate cancer: Reproducibility and clarification of issues. International Journal of Cancer. 96(3). 198–209. 19 indexed citations

20.

Roach, Mack, et al.. (1996). Three dimensional comparison of blocked arcs vs. four and six field conformal treatment of the prostate. Radiotherapy and Oncology. 41(1). 83–88. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact